Related Experiment Video
Updated: Nov 2, 2025
08:39
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
5.0K
Frontiers in Bladder Cancer Genomic Research
Yi Li1, Lihui Sun2, Xiangyang Guo1
1Department of Anesthesiology, Peking University Third Hospital, Beijing, China.
Frontiers in Oncology
|June 7, 2021
Summary
This review explores bladder cancer genomics, focusing on genetic alterations driving tumor growth, metastasis, and varied responses to chemotherapy. Understanding these genomic insights can improve diagnosis and treatment strategies.
Area of Science:
- Oncology
- Genetics
- Genomics
Background:
- Bladder cancer etiology often involves genetic changes like oncogene activation and tumor suppressor gene inactivation.
- Tumor heterogeneity in bladder cancer stems from genomic and proteomic alterations.
- High recurrence and metastasis rates necessitate combination therapies beyond surgery.
Purpose of the Study:
- To review current genomic research in bladder cancer.
- To correlate genomic findings with tumor occurrence, development, and metastasis.
- To examine genomic influences on patient chemosensitivity.
Main Methods:
- Comprehensive literature review of genomic studies on bladder cancer.
- Analysis of genetic alterations including mutations, rearrangements, and deletions.
- Synthesis of data on genome-proteome changes and chemosensitivity.
Main Results:
- Genomic instability is a hallmark of bladder cancer development and progression.
- Specific genetic mutations are linked to tumor aggressiveness and metastatic potential.
- Patient chemosensitivity varies significantly, influenced by underlying genomic profiles.
Conclusions:
- Genomic research provides critical insights into bladder cancer pathogenesis.
- Targeted genomic analysis can aid in predicting treatment response and metastasis risk.
- Further genomic studies are essential for personalized bladder cancer diagnosis and therapy.
